Sierra Summit Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Sierra Summit Advisors's MRK Position: Q2 2026 in Review
Sierra Summit Advisors increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $41.4K and bringing the position to 21,917 shares worth $2.82M. The position accounts for 0.31% of the portfolio, ranked #52.
Sierra Summit Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sierra Summit Advisors held 21,917 shares of Merck worth $2.82M as of Q2 2026.
- Sierra Summit Advisors bought 354 Merck shares in Q2 2026, an estimated $41.4K.
- Merck made up 0.31% of Sierra Summit Advisors's portfolio in Q2 2026, its #52 holding.
- Sierra Summit Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.